PAREXEL, the company who ran the TGN1412 "elephant man" clinical trial, has been named the "Best Contract Research Organization (CRO)" by Scrip World Pharmaceutical News. The award was presented to PAREXEL at the fourth annual Scrip Awards ceremony held on December 10, 2008 in London, England. The Scrip Awards are designed to celebrate innovation and a continued commitment to improving healthcare worldwide.
1 comment:
Not surprising given that the company's COO Goldberg is a money seeker. Take the fact that his daughter gets in the car with a bunch of kids, gets a broken nose, and then he sues the insurance company for over a million dollars. Rumor is that the teenage daughter only missed 2 dance classes for the nose AND that she hasn't missed a beat since then.
Post a Comment